Hlib Chabaniuk

Camp4 Therapeutics Corp engages with SYNGAP1 community in Poland family day event

Camp4 Therapeutics Corp engages with SYNGAP1 community in Poland family day event
Camp4 Therapeutics joins SYNGAP1 event

Camp4 Therapeutics Corp executives, including Chief Medical Officer Yuri Maricich and Vice President and Head of Clinical Operations Biljana Bazdar- Vinovrski, participated in a SYNGAP1 Family Day in Poland hosted by CureSYNGAP1 Poland and CureSYNGAP.

The company representatives joined families, clinicians, and advocates to connect with the SYNGAP1 community and provide updates on clinical progress. Their involvement underscores the firm commitment to advancing research and support for those affected by SYNGAP1-related disorders.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.